Login / Signup

Combined (dual) drug therapy for the treatment of patent ductus arteriosus: last approach prior to ligation.

Mehmet Fatih DeveciHuseyin KayaSadik YurttutanMeral AlagozIsmail K GokceCemsit KarakurtUfuk U GulluMehmet OnculRamazan Ozdemir
Published in: Cardiology in the young (2022)
The researchers believe the success of ibuprofen and paracetamol in haemodynamically significant patent ductus arteriosus treatment may be due to their synergistic efficacy and inhibition of the prostaglandin synthesis pathway through different enzymes. The results of our retrospective trial suggest that combination therapy with paracetamol and ibuprofen can be attempted when monotherapy is unsuccessful in treating haemodynamically significant patent ductus arteriosus, especially in centres without a surgical department.
Keyphrases
  • combination therapy
  • clinical trial
  • emergency department
  • study protocol
  • replacement therapy
  • adverse drug